Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Gene-based CF therapeutic developed by Megabios and Glaxo Wellcome proves safe in humans

Oct. 20, 1998

FDA awards fast track status and development grant to Surfaxin

Oct. 20, 1998

New U.S. patent covers use of anti-CTGF antibodies to treat fibrotic disorders

Oct. 19, 1998

First FDA approval for once-daily use of an inhaled corticosteroid for asthma

Oct. 16, 1998

Collaborative agreements in the field of asthma signed by SkyePharma and Sepracor

Oct. 15, 1998

Trega concludes phase I testing of HP-228 inhalation formulation

Oct. 13, 1998

Neutrophil inhibitor peptides available for licensing from RCT

Oct. 13, 1998

FDA continues to support development of SciClone's CF Rx

Oct. 9, 1998

HMR announces Spanish launch of Telfast

Oct. 9, 1998

Anti-IgE antibody in the treatment of asthma: an interesting theory is validated

Oct. 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...